-
Unveiling the research landscape of Sustainable Development Goals and their inclusion in Higher Education Institutions and Research Centers: major trends in 2000-2017
Sustainable Development Goals are the blueprint to achieve a better and ...
read it
-
Chemistry research in India in a global perspective- A scientometrics profile
Papers from India are cited 14.68 times on average compared to cites per...
read it
-
Assessing public-private research collaboration: is it possible to compare university performance?
It is widely recognized that collaboration between the public and privat...
read it
-
Collaboration between Research Institutions and University Sector Using Cloud-based Environment
The high-tech cloud-based university environment formation, which would ...
read it
-
Ranking academic institutions on potential paper acceptance in upcoming conferences
The crux of the problem in KDD Cup 2016 involves developing data mining ...
read it
-
Multiple criteria hierarchy process for sorting problems under uncertainty applied to the evaluation of the operational maturity of research institutions
Despite the availability of qualified research personnel, up-to-date res...
read it
-
The impact of external innovation on new drug approvals: A retrospective analysis
Pharmaceutical companies are relying more often on external sources of i...
read it
Funding CRISPR: Understanding the role of government and private sector actors in transformative innovation systems
CRISPR/Cas has the potential to revolutionize medicine, agriculture, and the way we understand life itself. Understanding the trajectory of innovation, how it is influenced and who pays for it, is essential for such a transformative technology. The University of California and the Broad/Harvard/MIT systems are the two most prominent academic institutions involved in the research and development of CRISPR/Cas. Here we present a model of co-funding networks for CRISPR/Cas research at these institutions, using funding acknowledgments to build connections. We map papers representing 95 from these institutions grouped by the stage that each represents in the translational research process (as a biological phenomenon, as a research tool, and development and applications of these technologies), and use a novel technique to analyse the relationships between the structures of the co-funding networks, the phase of research, and funding sources. The co-funding subnetworks were similar in that US government research funding played the decisive role in early stage research. Research at Broad/Harvard/MIT is also strongly supported by philanthropic/charitable organizations in later stages of the translational research process, clustered around certain topics. Applications for CRISPR technologies were underrepresented, which bolsters findings on the preponderance of the US private sector in developing applications, and the disproportionate number of Chinese institutions filing patents for industrial and food systems applications. These network models raise fundamental questions about the role of the state in supporting breakthrough innovations, risk, reward, and the influence of the private sector and philanthropy over the trajectory of transformative technologies.
READ FULL TEXT
Comments
There are no comments yet.